Dixorders can also search for this author Detoxification benefits PubMed Hypertension and immune system disorders Hypertensipn. Regulatory T cells TREG and their roles in immune system with respect to immunopathological disorders. Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Download citation.

Hypertension and immune system disorders -

The AT2 receptor agonist increased IL production but decreased lipopolysaccharide-induced TNF-α and IL-6 production in a dose-dependent manner. As stated earlier, macrophage infiltration is almost universal in hypertension models and the findings of the latter study suggest that a shift of the pro- and anti-inflammatory cytokine profile of macrophages may preclude the development of hypertension.

Another organ in which inflammation may lead to increased blood pressure is the arterial vascular wall. Functionally deficient macrophages in osteopetrotic mice with a mutation in macrophage colony-stimulating factor rendered these mice resistant to the prohypertensive effects of angiotensin II infusion.

The authors observed that the blood pressure did not increase in diphtheria toxin-treated mice. Vascular stiffness may be both a cause and a consequence of hypertension.

Several cross-sectional clinical studies demonstrated significant associations of markers of systemic inflammation, such as CRP, with pulse wave velocity.

Of patients followed up for an average of 27 months, patients developed incident hypertension. The brachial-ankle pulse wave velocity was found to be an independent predictor of incident hypertension. Similarly, Kaess et al. Therefore, the available experimental and clinical data indicate a potential role of increased systemic inflammatory biomarkers, as well as inflammatory infiltration of the renal interstitium and vascular wall, in the development of de novo hypertension.

Because inflammation and oxidative stress are frequently coupled, such an interaction would be an attractive mechanism to explain changes that drive the stage for the development of hypertension.

Reactive oxygen species ROS produced in large amounts would overwhelm the neutralizing capacity of the antioxidative systems and may influence protein activity and cell function. Chabrashvili et al.

The kidneys of SHRs showed the increased expression of genes for the main components of phagocyte NADPH oxidase. This increased mRNA preceded the development of hypertension in the model and was notable in the nephron segments of the vasculature, macula densa and distal nephron, which preceded the development of hypertension.

The SHR kidney has an exaggerated tubuloglomerular feedback response, which may be due to the diminished availability of NO. The results of this experimental study support the hypothesis that superoxide generation mediated by the NADPH oxidase system in the aforementioned parts of the nephron may be the principle driving force for the development of hypertension.

Callera et al. Zalba et al. Conversely, animal studies showed that the attenuation of cellular oxidative stress by overexpression of superoxide dismutase SOD or treatment with antioxidants attenuated these blood pressure elevations.

By contrast, depletion of SOD exacerbated hypertension. Clinical studies confirmed that in patients with essential hypertension, blood pressure levels are positively correlated with markers of oxidative stress. An increased local ROS concentration in the kidney may have a pivotal role in the generation of hypertension.

ROS-induced vascular remodeling impairs autoregulation and may lead to distal tubulointerstitial ischemia. Aortic stiffening is associated with the development of hypertension. A common denominator of various conditions associated with aortic stiffening is increased vascular oxidative stress.

Increased oxidative stress in the vascular wall is closely and highly related to inflammatory infiltration. Several researchers postulated the role of modification of self-proteins, such as isoketals, also known as isolevuglandins. The modified self-proteins then behave as autoantigens and elicit an inflammatory reaction.

Thus, increased oxidative stress may be a major culprit in the development of inflammatory infiltration, fibrosis and ensuing elevated blood pressures.

In summary, increased oxidative stress in renal and arteriolar vascular tissues may lead to increased blood pressure and could be an effector pathway for a number of pathophysiological disorders.

The Harrison group proposed that oxidative stress behaves as the effector mechanism and final common pathway for a number of pathophysiologic conditions, including immune, endocrine, neural, vascular and genetic disorders mosaic theory of hypertension.

The clearcut answer to this essential question has yet to be determined, but polymorphisms in antioxidant system enzymes, such as glutathione S -transferase and NADPH oxidase, may account for the interindividual differences in the levels of pro-oxidant molecules and antioxidative capacity.

Clinical studies related to hypertension and inflammation are summarized in Table 1. We now propose that different subtypes of immune cells, with various and considerably different functions, may have led to such conflicting results.

A better understanding of the various cell subtypes and corresponding functions has allowed scientists to conduct new studies with promising results, which implicate several aspects of immune dysregulation in the pathophysiology of hypertension.

Recent studies focused primarily on the role of T cells in the development of hypertension. Interestingly, the adoptive transfer of T cells, but not B cells, restored the blood pressure response in these mice. The authors also demonstrated that activated T cells can stimulate the vascular production of superoxide.

Mahdur et al. Although the initial hypertensive response was similar, hypertension was not sustained in mice lacking IL The authors concluded that ILproducing T cells are required for the development of sustained hypertension.

In contrast to the proinflammatory actions of TH1 and T helper type 17 TH17 lymphocytes, regulatory T cells suppress inflammatory reactions.

IL is one of the main cytokines produced by these cells. Exogenous IL normalizes blood pressure and endothelial function in a rodent model of pregnancy-induced hypertension. Despite compelling evidence for T-cell involvement as part of the adaptive immune system in the generation and propagation of hypertension, it remains to be determined why T cells infiltrate the kidney, vascular wall and central nervous system.

Is it simply a phenomenon secondary to chemokines produced from the reaction of the innate immune system, or is there a specific antigen, not yet identified, involved in the localized adaptive immune response? Neoantigens are endogenous molecules modified in response to oxidative stress, protein cleavage and intracellular release.

These proteins are expressed in the cytoplasm and function as chaperones to guide protein folding. To confirm the putative role of HSPs as the drivers of low-grade inflammation in hypertension, Parra et al.

Each model had a 2—4-fold increase in renal HSP70 expression. Furthermore, T cells isolated from the spleens demonstrated a significant 2—9-fold increased proliferative response when cultured in medium containing HSP70 compared with controls.

The same group confirmed the role of HSP70 as part of a likely autoimmune process in an elaborately designed rat study. A diet rich in salt is implicated as a possible cause of increased inflammation and the autoimmune response.

Experimental studies demonstrated that environmental factors boost the growth of TH17 lymphocytes. Increased salt in the diet may lead to the growth of TH17 cells and upregulation of proinflammatory cytokines, such as GM-CSF granulocyte—macrophage colony-stimulating factor , TNF-α and IL There is no large-scale clinical evidence demonstrating the role of T cells in the pathogenesis of human hypertension.

The possibility of a pathogenic role for lymphocytes in essential hypertension is based on observations in patients with AIDS. Seaberg et al. Other small studies also lend support to the role of lymphocytes and HSP70 in human hypertension. Mycophenolate mofetil is a prodrug of mycophenolic acid, which inhibits lymphocyte inosine monophosphate dehydrogenase, thereby inhibiting lymphocyte proliferation.

These patients also had stage 1 hypertension, and administration of mycophenolate mofetil without a change in other drugs led to a significant reduction in blood pressure levels. Mycophenolate mofetil treatment also reduced the urinary excretion of TNF-α.

Expression of HSP70 family members is triggered during stress or injury, including infections, increased oxidative stress and cytokines. Arterial vascular cells produce HSPs to protect themselves against these deleterious conditions. Studies also linked HSPs to acute hypertension.

The gut microbiota is dominated to a large extent by Firmicutes and Bacteroidetes and to a lesser extent by Actinobacteria and Proteobacteria. The Firmicutes to Bacteroidetes ratio was recently reported as increased in SHRs, angiotensin II-induced hypertensive rats and a small group of humans with essential hypertension.

In addition, the oral administration of minocycline reduced both the Firmicutes to Bacteroidetes ratio and the blood pressure of SHRs and rats with angiotensin II-induced hypertension. One mechanism relating gut microbiota to hypertension is an increased level of toxic metabolites, including P -cresol sulfate, indoxyl sulfate and trimethylamine N-oxide, which are known by-products of protein fermentation by the gut microbiota.

Perhaps, more importantly, gut microbiota, particularly with regard to intestinal wall inflammation, has been linked to the presence and severity of systemic inflammation. Several studies have shown that the level of Gram-negative bacteria endotoxin and bacterial DNA fragments in the systemic circulation are correlated with increased plasma CRP, IL-6 and d -lactate.

Interestingly, d -lactate is a marker of intestinal wall permeability to bacteria and toxins from the gut lumen. Therefore, this preliminary evidence shows that gut microbiota may be related to hypertension Figure 2.

Studies are needed to highlight the underlying mechanisms in different hypertensive species, such as Dahl salt-sensitive and salt-resistant rats and SHRs, for projection in human studies. Accruing experimental and clinical evidence supports the inflammatory and autoimmune aspects of essential hypertension.

Oxidative stress and inflammatory infiltration, both in the renal interstitium and vascular wall, may lead to mechanistic changes, which culminate in elevated blood pressure. However, because oxidative stress and inflammation are inseparably interconnected and can trigger and amplify each other, it is difficult to determine which precedes the other.

Although it is clear that innate and adaptive immune systems are involved in the development of essential hypertension, it is premature at this time to define hypertension as an autoimmune disease.

Although much progress has been made, further studies are needed to identify specific antigen s or factor s that drive low-grade inflammation and stimulate the adaptive immune response in subjects with essential hypertension.

Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, Park JR, Kim SW. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens ; 16 : — Article CAS Google Scholar. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers C-reactive protein, interleukin-6, and TNF-alpha and essential hypertension.

J Hum Hypertens ; 19 : — Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens ; 19 : — Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM.

C-reactive protein and the risk of developing hypertension. JAMA ; : — Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women.

Hypertension ; 49 : — King DE, Egan BM, Mainous AG III, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens Greenwich ; 6 : — Mattace-Raso FU, Verwoert GC, Hofman A, Witteman JC. Inflammation and incident-isolated systolic hypertension in older adults: the Rotterdam study.

J Hypertens ; 28 : — Bendich A, Belisle EH, Strausser HR. Immune system modulation and its effect on the blood pressure of the spontaneously hypertensive male and female rat. Biochem Biophys Res Commun ; 99 : — Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ.

Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol ; : F—F Heijnen BF, Van Essen H, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA. Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats.

Hypertens Res ; 37 : — Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats.

Hypertension ; 41 : — Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension ; 57 : — Rodriguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chavez M, Herrera-Acosta J, Johnson RJ, Pons HA.

Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Article Google Scholar. Quiroz Y, Pons H, Gordon KL, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ, Rodríguez-Iturbe B.

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol ; : F38—F Rodriguez-Iturbe B, Franco M, Johnson RJ. Impaired pressure natriuresis is associated with interstitial inflammation in salt-sensitive hypertension.

Curr Opin Nephrol Hypertens ; 22 : 37— Tinsley JH, South S, Chiasson VL, Mitchell BM. Interleukin reduces inflammation, endothelial dysfunction, and blood pressure in hypertensive pregnant rats. Am J Physiol Regulat Integr Compar Physiol ; : R—R Dhande I, Ma W, Hussain T. Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin production.

Hypertens Res ; 38 : 21— De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.

Arterioscler Thromb Vasc Biol ; 25 : — Wenzel P, Knorr M, Kossmann S, Stratmann J, Hausding M, Schuhmacher S, Karbach SH, Schwenk M, Yogev N, Schulz E, Oelze M, Grabbe S, Jonuleit H, Becker C, Daiber A, Waisman A, Münzel T. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction.

Circulation ; : — Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension ; 46 : — Pietri P, Vyssoulis G, Vlachopoulos C, Zervoudaki A, Gialernios T, Aznaouridis K, Stefanadis C.

Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens ; 24 : — Zheng X, Jin C, Liu Y, Zhang J, Zhu Y, Kan S, Wu Y, Ruan C, Lin L, Yang X, Zhao X, Wu S.

Arterial stiffness as a predictor of clinical hypertension. J Clin Hypertens Greenwich ; 17 : — Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS, Mitchell GF.

Aortic stiffness, blood pressure progression, and incident hypertension. Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol ; 31 : — Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS.

Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension ; 39 : — Callera GE, Touyz RM, Teixeira SA, Muscara MN, Carvalho MH, Fortes ZB, Nigro D, Schiffrin EL, Tostes RC. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension.

Hypertension ; 42 : — Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, Díez J. Hypertension ; 35 : — Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases.

Hypertension, or high blood pressure, is the most common chronic disease in America. People with hypertension are at risk for heart attack, stroke, and kidney damage. Did you know that there is a connection between hypertension and autoimmune disease? Were you aware there are over different causal factors in hypertension?

Autoimmunity is when your immune system attacks healthy cells in your body by mistake. The immune system is supposed to protect the body from infection and disease, but sometimes it breaks down and targets our own tissues.

Studies have shown that people with autoimmune diseases are more likely to develop hypertension, and vice versa.

One study found that people with the autoimmune disease systemic lupus erythematosus SLE , the most common type of lupus , were twice as likely to have hypertension than the general population.

In fact, hypertension may even be autoimmune in itself. In this blog post, we will discuss the link between these two conditions and how our functional medicine approach can address them.

T cells are a type of immune cell that helps the body fight infection. There are different types of T cells, including helper T cells and killer T cells. Helper T cells give instructions to other immune cells, and killer T cells kill infected or cancerous cells.

Some T cells, called regulatory T cells or T-reg cells, help to keep the immune system in check. This can happen because of genetics, infections, exposure to certain chemicals or drugs, or hypertension.

As a result, the immune system starts attacking healthy cells instead of fighting off infection. Autoimmunity can lead to a number of different diseases, including rheumatoid arthritis RA , lupus , and multiple sclerosis MS.

T cells are a normal part of the immune system, but they can cause serious problems if they become overactive, as they do in autoimmune disease. T cells can cause high blood pressure, or hypertension.

Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals.

Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL. Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis. Franco M, Tapia E, Santamaría J, Zafra I, García-Torres R, Gordon KL, et al. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure.

Venegas-Pont M, Mathis KW, Iliescu R, Ray WH, Glover PH, Ryan MJ. Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosus. Yue C, Li G, Wen Y, Li X, Gao R. Early renin-angiotensin system blockade improved short-term and long-term renal outcomes in systemic lupus erythematosus patients with antiphospholipid-associated nephropathy.

Lightfoot YL, Blanco LP, Kaplan MJ. Metabolic abnormalities and oxidative stress in lupus. Sinha N, Dabla PK. Oxidative stress and antioxidants in hypertension-a current review. Curr Hypertens Rev. Glennon-Alty L, Hackett AP, Chapman EA, Wright HL. Neutrophils and redox stress in the pathogenesis of autoimmune disease.

Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. Liu Y, Kaplan MJ. Cardiovascular disease in systemic lupus erythematosus: an update.

Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin Immunopathol. Data suggest that sera from a subset of SLE patients degraded NETs poorly due to the presence of DNase1 inhibitors or anti-NET antibodies that prevent DNase1 access to NETs.

Impaired DNase1 function and NET degradtion correlated with renal involement in this patient population. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al.

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. Lee HT, Wu TH, Lin CS, Lee CS, Wei YH, Tsai CY, et al.

The pathogenesis of systemic lupus erythematosus - from the viewpoint of oxidative stress and mitochondrial dysfunction. Forbes JM, Thorburn DR.

Mitochondrial dysfunction in diabetic kidney disease. Perl A, Hanczko R, Doherty E. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.

Methods Mol Biol Clifton, NJ. Download references. This study was funded by VA Merit Award BX 1A2 to MJR, AHA 18PRE to VLW, NIH P01HL, P20GM, U54GM, R01HL, T32HL to UMMC Physiology. Sonny Montgomery Veterans Affairs Medical Center, Jackson, USA. You can also search for this author in PubMed Google Scholar.

Correspondence to Michael J. Ryan reports grants from Veterans Affairs, grants from NIH, grants from AHA, during the conduct of the study.

Wolf declares no conflicts of interest relevant to this manuscript. This article does not contain any studies with human or animal subjects performed by any of the authors.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This article is part of the Topical Collection on Inflammation and Cardiovascular Diseases. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.

Reprints and permissions. Wolf, V. Autoimmune Disease-Associated Hypertension. Curr Hypertens Rep 21 , 10 Download citation. Published : 02 February Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Download PDF. Abstract Purpose of Review To highlight important new findings on the topic of autoimmune disease-associated hypertension.

Recent Findings Autoimmune diseases including systemic lupus erythematosus and rheumatoid arthritis are associated with an increased risk for hypertension and cardiovascular disease. Summary This review examines the prevalent hypertension in autoimmune disease with a focus on the impact of immune system dysfunction on vascular dysfunction and renal hemodynamics as primary mediators with oxidative stress as a main contributor.

Diagnosis and management of autoimmune diseases in the ICU Article 19 December The Different Therapeutic Choices with ARBs. Which One to Give? Article Open access 03 March Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis Article Open access 01 June Use our pre-submission checklist Avoid common mistakes on your manuscript.

Hypertension Is Prevalent in Patients with Autoimmune Disease Clinical evidence shows that there is a strong association between autoimmune diseases like SLE and RA with hypertension [ 16 ]. Risk Factors for Autoimmune Disease and Hypertension Both SLE and hypertension are multifactorial diseases. Genetic Factors Numerous susceptibility genes have been identified in the pathogenesis of autoimmune diseases.

Sex-Specific Factors The idea that the immune system can impact blood pressure in a sex-dependent manner is supported by numerous studies summarized in these recent reviews [ 48 , 49 , 50 ]. Metabolic Factors Autoimmune diseases like SLE are commonly associated with metabolic changes including insulin resistance and dyslipidemia [ 55 ].

Immune System Dysfunction: The Role of B and T Cells Recent studies from our laboratory demonstrated a key mechanistic role of immune system dysfunction in hypertension associated with autoimmunity in the NZBWF1 female mouse model of SLE [ 10 , 11 , 60 ].

Vascular Dysfunction Numerous studies reported that patients with SLE or RA exhibit impaired vascular function as measured by endothelial dependent, flow-mediated dilatation [ 78 , 79 ].

Renal Hemodynamics Body salt and fluid homeostasis and are essential for normal blood pressure control, and renal hemodynamic changes that lead to increased sodium and water reabsorption and extracellular fluid volume underlie the development of hypertension.

Alterations in Glomerular Filtration Rate and Renal Blood Flow Surprisingly, little is known about how the immunological changes that occur in patients with autoimmune disease directly impact renal hemodynamic function and increase the risk of developing hypertension.

Renin-Angiotensin System The renin-angiotensin system RAS is widely recognized for its role in blood pressure control and is also recognized for its role as a proinflammatory mediator. Oxidative Stress Reactive oxygen species ROS , such as superoxide anion, hydrogen peroxide, and hydroxyl anion, are known to play a major role in the tissue damage associated with autoimmune disease and in the development of hypertension [ 98 , 99 ].

Neutrophils Neutrophils are specialized phagocytic cells of the innate immune system that play a key role in the release of ROS during an autoimmune inflammatory response [ ]. Mitochondrial Dysfunction Apoptosis and NETosis are both energy-consuming processes that require mitochondria as an energy source, and mitochondria are a major cellular source of intracellular ROS generation [ ].

Conclusions The management of high blood pressure in patients with autoimmune disease should be considered a major aspect of their treatment plan. Article PubMed Google Scholar Barbour KE, Helmick CG, Boring M, Brady TJ. Article PubMed PubMed Central Google Scholar Giannelou M, Mavragani CP.

Article PubMed Google Scholar Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, et al. Article CAS Google Scholar Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Article PubMed Google Scholar Ikdahl E, Wibetoe G, Rollefstad S, Salberg A, Bergsmark K, Kvien TK, et al.

Article CAS PubMed Google Scholar Mathis KW, Taylor EB, Ryan MJ. Article CAS PubMed PubMed Central Google Scholar Taylor EB, Ryan MJ. Article CAS PubMed PubMed Central Google Scholar Rodriguez-Iturbe B.

Article CAS PubMed Google Scholar Small HY, Migliarino S, Czesnikiewicz-Guzik M, Guzik TJ. Article CAS PubMed Google Scholar Solak Y, Afsar B, Vaziri ND, Aslan G, Yalcin CE, Covic A, et al.

Article CAS PubMed Google Scholar Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, et al. Article CAS Google Scholar Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV.

PubMed Google Scholar Al-Herz A, Ensworth S, Shojania K, Esdaile JM. PubMed Google Scholar Sabio JM, Vargas-Hitos JA, Navarrete-Navarrete N, Mediavilla JD, Jimenez-Jaimez J, Diaz-Chamorro A, et al.

Article PubMed Google Scholar Shaharir SS, Mustafar R, Mohd R, Mohd Said MS, Gafor HA. Article PubMed Google Scholar Shanmugam VK, Steen VD. Article Google Scholar Jafri S, Ormiston ML.

Article CAS PubMed Google Scholar Mohan C, Putterman C. Article CAS PubMed Google Scholar Judd E, Calhoun DA. Article PubMed PubMed Central Google Scholar Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, et al.

Article PubMed Google Scholar Duran-Barragan S, McGwin G Jr, Vila LM, Reveille JD, Alarcon GS, cohort LamU. Article CAS Google Scholar Ravenell RL, Kamen DL, Spence JD, Hollis BW, Fleury TJ, Janech MG, et al.

Article PubMed PubMed Central Google Scholar Barbhaiya M, Costenbader KH. Article CAS PubMed PubMed Central Google Scholar Teh P, Zakhary B, Sandhu VK.

Article CAS PubMed Google Scholar Ku IA, Imboden JB, Hsue PY, Ganz P. Article CAS Google Scholar Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Article CAS Google Scholar Kaufman KM, Kelly J, Gray-McGuire C, Asundi N, Yu H, Reid J, et al. Article CAS Google Scholar Lee YH, Choi SJ, Ji JD, Song GG.

Article CAS PubMed Google Scholar Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. CAS PubMed Google Scholar Joung CI, Park YW, Kim SK, Uhm WS, Kim TH, Yoo DH.

Article CAS PubMed PubMed Central Google Scholar Van Raemdonck K, Umar S, Szekanecz Z, Zomorrodi RK, Shahrara S. Article PubMed Google Scholar Massarenti L, Enevold C, Damgaard D, Odum N, Nielsen CH, Jacobsen S. Article CAS PubMed Google Scholar Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C.

Article CAS Google Scholar Haque UJ, Bathon JM, Giles JT. Article CAS Google Scholar Gao CC, Liu SY, Wu ZZ, Li TF, Gao GM, Liu ZS, et al. Article CAS PubMed Google Scholar Mak A. Article CAS PubMed Google Scholar Wang Y, Zhu J, DeLuca HF.

Article CAS PubMed Google Scholar Sabio JM, Vargas-Hitos JA, Martinez Bordonado J, Mediavilla-Garcia JD. Article CAS PubMed Google Scholar Norlander AE, Madhur MS, Harrison DG. Article CAS PubMed PubMed Central Google Scholar Crislip GR, Sullivan JC.

Article CAS Google Scholar Caillon A, Paradis P, Schiffrin EL. Article CAS PubMed PubMed Central Google Scholar Ramirez LA, Sullivan JC. Article PubMed Google Scholar Gilbert EL, Mathis KW, Ryan MJ. Article CAS PubMed Google Scholar Gilbert EL, Ryan MJ.

Article CAS PubMed PubMed Central Google Scholar Margiotta D, Navarini L, Vadacca M, Basta F, Lo Vullo M, Pignataro F, et al. CAS PubMed Google Scholar Abella V, Scotece M, Conde J, López V, Lazzaro V, Pino J, et al.

Article CAS PubMed PubMed Central Google Scholar Bravo PE, Morse S, Borne DM, Aguilar EA, Reisin E. Article CAS Google Scholar Tian G, Liang JN, Wang ZY, Zhou D. Article CAS PubMed Google Scholar Mathis KW, Wallace K, Flynn ER, Maric-Bilkan C, LaMarca B, Ryan MJ.

Article CAS PubMed PubMed Central Google Scholar Alshaiki F, Obaid E, Almuallim A, Taha R, El-Haddad H, Almoallim H. Article PubMed PubMed Central Google Scholar Karasawa K, Uchida K, Takabe T, Moriyama T, Nitta K. Article PubMed Google Scholar Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B.

Article CAS PubMed Google Scholar Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, and Voll RE. Article CAS Google Scholar Crispin JC, Martinez A, Alcocer-Varela J.

Article Google Scholar Liu MF, Wang CR, Fung LL, Wu CR. Article Google Scholar Valencia X, Yarboro C, Illei G, Lipsky PE. Article CAS Google Scholar Wu HY, Staines NA. Article CAS PubMed Google Scholar Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S. Article CAS PubMed Google Scholar Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI.

Article CAS Google Scholar Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, et al. Article CAS PubMed Google Scholar Mian MO, Barhoumi T, Briet M, Paradis P, Schiffrin EL.

Article CAS PubMed Google Scholar Matrougui K, Abd Elmageed Z, Kassan M, Choi S, Nair D, Gonzalez-Villalobos RA, et al. Article CAS PubMed PubMed Central Google Scholar Kuhn C, Weiner HL. Article CAS Google Scholar Liu Y, Deng W, Meng Q, Qiu X, Sun D, Dai C.

Article CAS PubMed Google Scholar Norlander AE, Saleh MA, Kamat NV, Ko B, Gnecco J, Zhu L, et al. Article CAS PubMed PubMed Central Google Scholar Sodergren A, Karp K, Boman K, Eriksson C, Lundstrom E, Smedby T, et al.

Article CAS PubMed PubMed Central Google Scholar Mak A, Kow NY, Schwarz H, Gong L, Tay SH, Ling LH. Article CAS PubMed PubMed Central Google Scholar Vazquez-Del Mercado M, Gomez-Banuelos E, Chavarria-Avila E, Cardona-Munoz E, Ramos-Becerra C, Alanis-Sanchez A, et al.

Article Google Scholar Yong WC, Sanguankeo A, Upala S. Article CAS Google Scholar Bijl M. CAS PubMed Google Scholar Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Article CAS Google Scholar Lewis MJ, Vyse S, Shields AM, Zou L, Khamashta M, Gordon PA, et al.

Article CAS PubMed PubMed Central Google Scholar Molad Y, Miroshnik E, Sulkes J, Pitlik S, Weinberger A, Monselise Y. CAS PubMed Google Scholar Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG.

Article CAS Google Scholar Nakatani K, Fujii H, Hasegawa H, Terada M, Arita N, Ito MR, et al. Article CAS PubMed Google Scholar Bomback AS, Appel GB. Article CAS PubMed Google Scholar Bomback AS. Article Google Scholar Avar Aydin PO, Shan J, Brunner HI, Mitsnefes MM.

Article CAS PubMed Google Scholar Nakano M, Ueno M, Hasegawa H, Watanabe T, Kuroda T, Ito S, et al. Article CAS Google Scholar Mori S, Yoshitama T, Hirakata N, Ueki Y.

Article PubMed PubMed Central Google Scholar Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL. Article CAS PubMed Google Scholar Franco M, Tapia E, Santamaría J, Zafra I, García-Torres R, Gordon KL, et al. CAS PubMed Google Scholar Venegas-Pont M, Mathis KW, Iliescu R, Ray WH, Glover PH, Ryan MJ.

Article CAS PubMed PubMed Central Google Scholar Yue C, Li G, Wen Y, Li X, Gao R. Article CAS PubMed Google Scholar Lightfoot YL, Blanco LP, Kaplan MJ.

Article CAS PubMed PubMed Central Google Scholar Sinha N, Dabla PK. Article CAS Google Scholar Glennon-Alty L, Hackett AP, Chapman EA, Wright HL.

Article CAS PubMed Google Scholar Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al.

Article CAS PubMed PubMed Central Google Scholar Liu Y, Kaplan MJ. Article CAS PubMed PubMed Central Google Scholar Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al.

Article PubMed PubMed Central Google Scholar Lee HT, Wu TH, Lin CS, Lee CS, Wei YH, Tsai CY, et al. Article CAS PubMed Google Scholar Forbes JM, Thorburn DR.

Article CAS PubMed Google Scholar Perl A, Hanczko R, Doherty E. Article CAS Google Scholar Download references. Funding This study was funded by VA Merit Award BX 1A2 to MJR, AHA 18PRE to VLW, NIH P01HL, P20GM, U54GM, R01HL, T32HL to UMMC Physiology.

Ryan G. Sonny Montgomery Veterans Affairs Medical Center, Jackson, USA Michael J. Ryan Authors Victoria L. Wolf View author publications. View author publications. Ethics declarations Conflict of Interest Dr. Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors.

Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 4. About this article. Cite this article Wolf, V. Copy to clipboard. search Search by keyword or author Search.

Hypertension is the primary cause of cardiovascular disease, which Hypertension and immune system disorders a leading disordegs worldwide. Current therapeutic options focus primarily on lowering blood pressure through decreasing peripheral resistance Hypertension and immune system disorders ane fluid volume, but fewer Hypertenskon half Calorie intake for diabetics hypertensive patients Hyperttension reach blood Hyperetnsion control. Hence, identifying unknown mechanisms causing essential hypertension and designing new treatment accordingly are critically needed for improving public health. In recent years, the immune system has been increasingly implicated in contributing to a plethora of cardiovascular diseases. Many studies have demonstrated the critical role of the immune system in the pathogenesis of hypertension, particularly through pro-inflammatory mechanisms within the kidney and heart, which, eventually, drive a myriad of renal and cardiovascular diseases. However, the precise mechanisms and potential therapeutic targets remain largely unknown. Hypertension and immune system disorders Hypeetension of immune cells in the initiation and Environmentally-friendly packaging of hypertension is undeniable. Several studies have immkne the association between Sjstem, inflammation, and immune cells from the innate and adaptive immune systems. Here, we provide an update to our American Journal of Hypertension review on the overview of the cellular immune responses involved in hypertension. Further, we discuss the activation of immune cells and their contribution to the pathogenesis of hypertension in different in vivo models. We also highlight existing gaps in the field of hypertension that need attention.